Strategy, Yield and Risks of Controlling Plasma Lipids in the Primary Prevention of Coronary Heart Disease
Reference35 articles.
1. I. Holme, S. C. Enger, A. Helgeland, I. Hjermann, Paul Leren, P. G. Lund-Larson, L. A. Solberg, and J. P. Strong, Risk factors and raised atherosclerotic lesions in coronary and cerebral arteries, Statistical analysis from the Oslo Study, Arteriosclerosis 1: 250 – 256 (1981).
2. The Pooling Project Research Group, Relationship of blood pressure serum cholesterol, smoking habit, relative weight and ECG abnormalities to incidence of major coronary events, Final report of the Pooling Project, J. Chron. Dis. 31: 201 – 306 (1978).
3. G. Rose, P. J. S. Hamilton, H. Keen, D. D. Reed, P. McCartney, and R. J. Jarrett, Myocardial ischaemia, risk factors and death from coronary heart disease, Lancet 1: 105 – 109 (1977).
4. U. Goldbourt and J. H. Medalie, Lipoprotein cholesterol and the incidence of coronary heart disease - the Israeli Ischaemic Heart Disease Study, AMA. J. Epidemiol. 109: 296 – 307 (1975).
5. L. E. Bottiger and L. A. Carlson, Risk factors for ischaemic vascular death from men in the Stockholm Prospective Study, Atherosclerosis 36: 389 – 408 (1980).